InBios International
Mark Evashenk is a seasoned professional with extensive experience in clinical operations, currently serving as the Director of Clinical Operations at ALZA Corporation, a subsidiary of Johnson & Johnson Pharma, where Mark has been since 2006. In addition to this role, Mark also holds the title of Clinical Program Leader, demonstrating a strong commitment to advancing clinical programs and ensuring operational excellence within the organization.
This person is not in any offices
InBios International
InBios is a leading biotechnology company based in Seattle, Washington (USA). At InBios, we believe an accurate diagnosis is the first step to effective treatment. Specializing in the design, development and manufacture of immunodiagnostic devices for infectious diseases and biothreats, we strive to improve health outcomes globally by providing superior quality products that are accurate, easy to use and cost effective.